BridgeMD
Tests treatment safety and results for Ovarian Cancer
Official title A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer
ClinicalTrials.gov ID: NCT07069335
What this study is testing
What is Olaparib 150 MG?
Olaparib 150 MG is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for ovarian cancer.
Also referred to as BR2022.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This was a multicenter, open-label, randomized, crossover bioequivalence study to evaluate the pharmacokinetics and safety of BR2022 and BR2022-1 in Patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian cancer.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 74, women only
You may be able to join if
- Females aged 19 -74 at the time of consent
- Those who voluntarily signed the informed consent to participate in this study
- Patients with deleterious or suspected deleterious germline or somatic BRCA-mutated advanced epithelial ovarian, fallopian tube, or primary...
You likely can't join if
- Those who have a history of severe hypersensitivity to drugs that include the ingredients of the investigational product or have a history of...
- Those who have gastrointestinal disorders (e.g., gastroesophageal reflux disease, gastrospasm, gastritis, gastrointestinal ulcers, Crohn's disease...
- Those who are pregnant, suspected of pregnancy, or nursing
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Songpa District, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Songpa District, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.